Incremental diagnostic yield of loop electrocardiographic recorders in unexplained syncope☆
References (25)
- et al.
The role and limitations of elcctrophysiologic testing in patients with syncope
Int J Cardiol
(1983) - et al.
Diagnostic efficacy of 24-hour electrocardiographic monitoring for syncope
Am J Cardiol
(1984) - et al.
Recurrent syncope of unknown origin diagnosed by ambulatory continuous loop ECG recording
Am Heart J
(1988) - et al.
Psychiatric syncope
Psychosomatics
(1990) - et al.
The value of electrophysiologic studies in syncope of undetermined origin
Am Heart J
(1985) - et al.
Diagnostic utility of memory-equipped transtelephonic monitors
Am J Med Sci
(1988) - et al.
Cardiac and electrophysiologic hemodynamic correlates of neurally mediated syncope
Am J Cardiol
(1989) - et al.
Isoproterenol induction of vasodeprcssor-type reaction in vasodepressor-prone persons
Am J Cardiol
(1989) Syncope
South Med J
(1987)- et al.
A prospective evaluation and follow-up of patients with syncope
N Engl J Med
(1983)
Patients with syncope admitted to medical intensive care units
JAMA
(1982)
Syncope in a general hospital patient population
NY State Med J
(1983)
Cited by (230)
Silent atrial fibrillation detected by home-monitoring: Cardiovascular disease and stroke prevention in patients with diabetes
2020, Journal of Diabetes and its Complications2018 ACC/AHA/HRS Guideline on the Evaluation and Management of Patients With Bradycardia and Cardiac Conduction Delay: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society
2019, Journal of the American College of Cardiology2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society
2018, Journal of the American College of Cardiology
- ☆
This study was supported in part by grants from the Charles A. Dana Foundation, the Duke Women's Auxiliary, and grants HL24920, HL40392 and the Biomedical Research Grant Program (S07RR05405) from the National Institutes of Health, Bethesda, Maryland. This study was performed through the General Clinical Research Center (M-01, RR-30) at Duke University Medical Center. Monitoring equipment for this study was provided by Instromedix, Inc., Beaverton, Oregon. Research costs for patients undergoing monitoring with the King of Hearts recorder were also provided by Instromedix, Inc.
- 1
Dr. Linzer's current address: Division of General Medicine, New England Medical Center, Boston, Massachusetts 02111.
Copyright © 1990 Published by Elsevier Inc.